Going through old files and found this link from about Jan 2021 by the WHO:
https://extranet.who.int/pqweb/sites/default/files/documents/TAG-EUL_PublicReport_BioNTech_DEC20.pdf
Scroll down to section 3.4 risk management plan and see what it says.
And this is the document used by the WHO to "approve" this covid jab.
Some quotes:
missing information:
− Use in pregnancy and while breast feeding;
− Use in immunocompromised patients;
− Use in frail patients with co-morbidities (e.g. chronic obstructive pulmonary disease (COPD), diabetes, chronic neurological disease, cardiovascular disorders);
− Use in patients with autoimmune or inflammatory disorders Interaction with other vaccines;
− Interaction with other vaccines;
− Long term safety data.
results from the DART study in Wistar Han rats should be submitted as soon as they are available (expected to be complete on Q1 2021).
The clinical information is not complete because the clinical trial is still ongoing.
Reactions may be more severe after the second dose.
Limited safety data and follow-up to date
These populations were not included in the clinical trial program
.
Read some of these - mostly copy and pastes from other documents.
All one big group think circle jerk by the "experts".
https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/covid-19-materials
Excellent documentation!